FLNA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Filana Therapeutics, Inc (FLNA) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant trading trends, and no recent positive news or catalysts make this stock a hold. The stock's current price and technical indicators do not suggest a compelling entry point.
The stock closed at $1.73 with no significant price movement during the regular market session (+0.58%) but showed a pre-market decline of -4.07%. There are no clear upward or downward trends, and no significant trading trends from hedge funds or insiders have been observed.
NULL. There are no recent news updates, significant trading trends, or positive financial developments to act as a catalyst.
The company's financial performance is weak, with a significant YoY drop in net income (-54.56%) and EPS (-54.39%). No recent news or events provide a positive outlook. Additionally, there is no recent activity from influential figures or Congress trading data.
In Q4 2025, the company reported no revenue growth (0% YoY), a net income loss of -$12.54M (-54.56% YoY), and a drop in EPS to -0.26 (-54.39% YoY). Gross margin remains at 0%. Overall, the financials indicate poor performance.
No data available for analyst ratings or price target changes.
